 |
The Gut Health PodcastAuthor: Kate Scarlata and Megan Riehl
The Gut Health Podcast explores the scientific connection between the gut, food, mood, microbes and well-being. Kate Scarlata is a world-renowned GI dietitian and Dr. Megan Riehl is a prominent GI psychologist at the University of Michigan and both are the co-authors of Mind Your Gut: The Science-based, Whole-body Guide to Living Well with IBS. Their unique lens with which they approach holistic conversations with leading experts in the field of gastroenterology will appeal to the millions of individuals impacted by gut health. As leaders in their field, Kate and Megan dynamically plow through the common myths surrounding gut health and share evidence-backed information on navigating medical management, nutrition, behavioral interventions and more for those living with or without a GI condition.The Gut Health Podcast is where science, expertise, and two enthusiastic advocates for wellness come together to help you live your best life.Learn more about Kate and Megan at www.katescarlata.com and www.drriehl.com Instagram: @Theguthealthpodcast Language: en-us Genres: Health & Fitness, Medicine, Nutrition Contact email: Get it Feed URL: Get it iTunes ID: Get it Trailer: |
Listen Now...
Miracle or Misused? Benefits, Risks, and Responsible Use of GLP-1s
Episode 27
Thursday, 1 January, 2026
Glucagon-like peptide-1 (GLP-1) can transform metabolic health, but only with smart dosing, adequate dietary protein, regular strength training, and mental health support. In this episode, we explore how GLP-1 medications work in the brain and gut, why metabolic health is more than BMI or a weight on the scale, and how to use these drugs safely. Our expert guest, gastroenterologist, Dr Supriya Rao shares practical dosing, side effect strategies, and what makes results stick.• Defining metabolic health beyond BMI and weight• How GLP-1s reduce appetite and slow gastric emptying• Healthy weight loss pace and preserving lean muscle• Practical + science-backed dosing and individualized titration• The unknown risks of compounding and microdosing• Managing nausea, reflux, and constipation• Diet shifts: smaller meals, more fiber, adequate protein• Mental health, body image, and stigma in care• Durability of results and maintenance dosing• New indications: MASH (metabolic dysfunction-associated steatohepatitis), sleep apnea, cardiovascular protection• Building an educated care teamReferences/Resources:Tzang CC, Wu PH, Luo CA, Chen ZT, Lee YT, Huang ES, Kang YF, Lin WC, Tzang BS, Hsu TC. Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. EClinicalMedicine. 2025 Nov 28;90:103680. Ghusn W, Hurtado MD. Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks. Obes Pillars. 2024;12:100127. Published 2024 Aug 31. Moiz A, Filion KB, Tsoukas MA, Yu OHY, Peters TM, Eisenberg MJ. The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions. EClinicalMedicine. 2025 Jul 17;86:103363. Integrated Gastroenterology Consultants (Dr. Supriya Rao's practice site)Book: The GLP-1 Kitchen: A Cookbook for Living Well on Weight Loss Medications Escobar S-N et al. (contains affiliate marketing link)Learn more about Kate and Dr. Riehl:Website: www.katescarlata.com and www.drriehl.comInstagram: @katescarlata @drriehl and @theguthealthpodcastOrder Kate and Dr. Riehl's book, Mind Your Gut: The Science-Based, Whole-body Guide to Living Well with IBS. The information included in this podcast is not a substitute for professional medical advice, examination, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider before starting any new treatment or making changes to existing treatment.
